FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Somerset Therapeutics Private Methocarbamol Injection 1 Recall

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only…

Somerset Therapeutics Private Limited · Bengaluru, N/A

Risk level
Class II
Reported by FDA
Apr 16, 2025
Recall ID
D-0354-2025
Check your lot numberHow we source this data

Summary

Somerset Therapeutics Private recalled Methocarbamol Injection 1 starting Mar 21, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0354-2025 on Apr 16, 2025. Reason: Lack of Assurance of Sterility: Media fill with bacterial contamination. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility: Media fill with bacterial contamination

Product description

Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)

Lot numbers, UPCs & expiration codes

NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0354-2025
Classification
Class II
Status
Ongoing
Recall initiated
Mar 21, 2025
FDA report date
Apr 16, 2025
Quantity
506,080 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Somerset Therapeutics Private Limited

Original FDA data

Every field from FDA enforcement report D-0354-2025, exactly as published.

Show all FDA fields
City
Bengaluru
Status
Ongoing
Country
India
Event ID
96569
Address
54/1 Budihal Village
Code information
NDC 70069-101-25; A240304, A240305, A240320, A240322, A240334, A240335, A240340, exp. date 05/2026; A240342, A240347, A240385, A240391, exp. date 06/2026; NDC 70069-101-05; A240326, exp. date 05/2026
Report date
Apr 16, 2025
Product type
Drugs
Recall number
D-0354-2025
Classification
Class II
Recalling firm
Somerset Therapeutics Private Limited
Product quantity
506,080 vials
Reason for recall
Lack of Assurance of Sterility: Media fill with bacterial contamination
Voluntary / mandated
Voluntary: Firm initiated
Product description
Methocarbamol Injection USP 1,000 mg/10 mL (100 mg/mL), 10 mL Single Dose Vial, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Somerset, NJ 08873, NDC 70069-101-25 (immediate carton) and 70069-101-05 (5x10 mL carton)
Distribution pattern
U.S. Nationwide
Recall initiation date
Mar 21, 2025
Initial firm notification
Letter
Center classification date
Apr 8, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0354-2025, published Apr 16, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls